Home
About Us
About Us
Why Raglan
Careers
Selected Transactions
Raglan IPO Projects
Raglan Pharmaceutical & Life Science Projects
Raglan Natural Resources
News
Contact us
Search
Open Orphan
Interim Results for 6 months ended 30 June 2020
by lynchski
New £4.3m Challenge Study Contract Win
September 28, 2020
Amryt Pharma – Update On Ongoing AP101 Trial
Amryt
by lynchski
Amryt Pharma – Grant Funding From Irish Government For AP103
Amryt
by lynchski
Amryt Pharma – LOJUXTA To Be Reimbursed In France
Amryt
by lynchski
Amryt Pharma – Interim Results
Amryt
by lynchski
Amryt Pharma - Amryt Receives Ind Approval From FDA for AP101
Amryt
by lynchski
Amryt Pharma – FDA Grants Pediatric Rare Disease Designation
Amryt
by lynchski
Amryt Pharma – Trading Update & Significant Momentum Building
Amryt
by lynchski
Amryt Pharma - NHS England Approves Funding For LOJUXTA
Amryt
by lynchski
1
2
Privacy Preference Center
Privacy Preferences
